|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0290 USD | +6.62% |
|
+36.79% | -52.77% |
| 06-02 | CV Sciences, Inc. - Shareholder/Analyst Call | |
| 05-14 | CV Sciences, Inc., Q1 2026 Earnings Call, May 14, 2026 |
| Market Cap | 4.04M 3.54M 3.28M 3.02M 5.69M 389M 5.76M 39.15M 15.32M 191M 15.16M 14.83M 658M | P/E 2024 |
-2.48x | P/E 2025 | -11.8x |
|---|---|---|---|---|---|
| Enterprise Value | 5.76M 5.05M 4.68M 4.3M 8.11M 554M 8.21M 55.8M 21.84M 272M 21.61M 21.14M 938M | EV / Sales 2024 |
0.42x | EV / Sales 2025 | 0.95x |
| Free-Float |
92.21% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: CV Sciences, Inc.
| 1 day | +6.62% | ||
| 1 week | +36.79% | ||
| Current month | +19.34% | ||
| 1 month | +45.00% | ||
| 3 months | -14.71% | ||
| 6 months | -34.09% | ||
| Current year | -52.77% |
| 1 week | 0.02 | 0.03 | |
| 1 month | 0.02 | 0.03 | |
| Current year | 0.02 | 0.1 | |
| 1 year | 0.02 | 0.1 | |
| 3 years | 0.02 | 0.1 | |
| 5 years | 0.02 | 0.36 | |
| 10 years | 0.02 | 9.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 68 | 2018-05-30 |
Joerg Grasser
DFI | Director of Finance/CFO | 51 | 2019-03-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
BRD | Director/Board Member | 68 | 2018-05-30 |
Jamie Corroon
BRD | Director/Board Member | 56 | 2022-07-20 |
William McCorkle
BRD | Director/Board Member | 58 | 2022-10-20 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 2/18/25 | Free | Chief Executive Officer | 3,000,000 | 1.6281% | ||
| 2/18/25 | Free | Chief Financial Officer | 2,350,000 | 1.2753% | ||
| 2/18/25 | Free | Director | 500,000 | 0.2714% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +6.62% | +36.79% | -21.62% | -41.18% | 4.04M | ||
| +2.49% | +1.98% | +54.22% | +154.40% | 1,048B | ||
| +0.72% | -1.28% | +52.48% | +47.25% | 603B | ||
| +1.07% | +4.62% | +38.54% | +78.17% | 452B | ||
| +0.42% | +1.30% | +31.64% | +22.30% | 327B | ||
| +0.61% | +3.18% | +36.60% | +38.63% | 283B | ||
| +1.80% | +0.83% | +22.39% | +17.53% | 259B | ||
| -0.39% | -2.27% | -23.79% | -41.26% | 219B | ||
| +0.57% | +3.09% | +23.78% | +55.97% | 198B | ||
| -2.20% | +0.18% | +20.32% | +61.56% | 162B | ||
| Average | +1.06% | +1.56% | +23.46% | +39.34% | 355.17B | |
| Weighted average by Cap. | +0.94% | +1.69% | +38.08% | +73.34% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 15.7M 13.77M 12.75M 11.74M 22.14M 1.51B 22.4M 152M 59.57M 741M 58.95M 57.68M 2.56B | 13.79M 12.09M 11.2M 10.31M 19.44M 1.33B 19.67M 134M 52.3M 651M 51.76M 50.65M 2.25B |
| Net income | -2.39M -2.1M -1.94M -1.79M -3.37M -231M -3.42M -23.2M -9.08M -113M -8.99M -8.79M -390M | -958K -840K -778K -716K -1.35M -92.26M -1.37M -9.29M -3.63M -45.22M -3.6M -3.52M -156M |
| Net Debt | 325K 285K 264K 243K 458K 31.3M 464K 3.15M 1.23M 15.34M 1.22M 1.19M 52.96M | 1.72M 1.51M 1.4M 1.28M 2.42M 165M 2.45M 16.65M 6.52M 81.09M 6.45M 6.31M 280M |
Employees
43
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-21 | US$0.0198 | +10.00% | 525,767 |
| 26-07-20 | US$0.0180 | -10.00% | 528,130 |
| 26-07-17 | US$0.0200 | -2.44% | 1,039,549 |
| 26-07-16 | US$0.0205 | +6.99% | 262,469 |
| 26-07-15 | US$0.0192 | -9.41% | 126,569 |
- Stock Market
- Stocks
- CVSI Stock
Select your edition
All financial news and data tailored to specific country editions

















